Physician profile
Matan Yemini
NPI 1255415345
$932.79
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $81.27 · 2021: $91.36 · 2022: $151 · 2023: $206 · 2024: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $362.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $292.06 | 2019-2023 | Menopur |
| Medtronic, INC. | $159.84 | 2023 | Truclear |
| Hologic Sales and Service, LLC | $114.69 | 2024 | Myosure Tissue Removal Device |
| Organon LLC | $103.68 | 2021-2024 | Ganirelix Acetate, Follistim Aq |
| Emd Serono, INC. | $72.57 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $43.67 | 2019-2020 | |
| Coopersurgical, INC. | $42.20 | 2020-2022 | |
| Abbvie INC. | $25.25 | 2019 | |
| Vitrolife INC. | $20.53 | 2023 | |
| Olympus America INC. | $16.03 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.99 | 2019 | |
| Therapeuticsmd, INC. | $14.39 | 2019 | |
| Avion Pharmaceuticals | $12.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matan Yemini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.